It is hard to pick an area of material weakness in JPMorgan's 2Q18 results.
The consumer and investment banking businesses continue to look very robust, while markets are showing definitive signs of having recovered.
I would gladly consider adding JPM to my current BAC position, but would only do so within the context of a properly risk-balanced portfolio.
Propelled by strength across the portfolio, JPMorgan (NYSE:JPM) delivered a beautiful quarter this Friday morning.
Net revenues of $28.4 billion (on a managed basis) topped last year's $26.7 billion by 6%, with EPS